Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Acta Oncologica (Stockholm, Sweden)|September 2, 2008
Implementation and experimental validation of the high dose rate stereotactic treatment mode at Varian acceleratorsLone HoffmannActa Oncologica (Stockholm, Sweden)|September 23, 2008
Validation of Varian's AAA algorithm with focus on lung treatmentsHeidi S Rønde, Lone HoffmannActa Oncologica (Stockholm, Sweden)|July 31, 2015
Dosimetric evaluation of anatomical changes during treatment to identify criteria for adaptive radiotherapy in oesophageal cancer patientsTine Bisballe Nyeng, Marianne Nordsmark, Lone HoffmannJournal of Applied Clinical Medical Physics|September 24, 2025
Independent secondary dose calculation for patient-specific quality assurance: Quantitative benefit of Monte-Carlo and custom beam modelingLone Hoffmann, Mai-Britt Linaa, Ditte Sloth MøllerActa Oncologica (Stockholm, Sweden)|September 7, 2013
Inter-tester reproducibility of tumour change in small cell lung cancer patients undergoing chemoradiotherapyMai-Britt Bjørklund Ellegaard, Marianne Marquard Knap, Lone HoffmannActa Oncologica (Stockholm, Sweden)|September 14, 2010
Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patientsMarianne Marquard Knap, Lone Hoffmann, Marianne Nordsmark, et al.Medical Physics|June 17, 2018
Validation of the Acuros XB dose calculation algorithm versus Monte Carlo for clinical treatment plansLone Hoffmann, Markus Alber, Matthias Söhn, et al.Physics and Imaging in Radiation Oncology|January 18, 2021
Cone beam CT based dose calculation in the thorax regionLaura Patricia Kaplan, Ulrik Vindelev Elstrøm, Ditte Sloth Møller, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2013
Adaptive radiotherapy of lung cancer patients with pleural effusion or atelectasisDitte Sloth Møller, Azza Ahmed Khalil, Marianne Marquard Knap, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 4, 2017
Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverageLone Hoffmann, Markus Alber, Maria Fuglsang Jensen, et al.Pageof 8